In the last part of November 2025, Eli Lilly and Company (NYSE: LLY) shattered a historic ceiling. The Indianapolis-based drugmaker became the first pharmaceutical company to reach a market capitalization of $1 trillion. This milestone places Lilly in an elite financial weight class previously dominated by technology sector giants.
Historically, pharmaceutical stocks trade at lower valuations than technology companies, as investors often worry about patent cliffs (where profitable drugs lose protection and face cheap competition) as well as regulatory risks.
